邻近类别 會議論文/會議摘要 [23/37] 專利 [0/18] 类别统计 近3年内发表的文件:19(12.10%) 含全文笔数:157(100.00%) 文件下载次数统计 下载大于0次:157(100.00%) 下载大于100次:153(97.45%) 全文下载总次数:84386(86.93%) 最后更新时间: 2024-11-28 14:27 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... Discovery of a long half-life AURKA... Postfermented tea extract potently ... Natural fucoidans inhibit coronavir... Development of furanopyrimidine-bas... The synergistic inhibition of coron... Omicron-specific mRNA vaccine induc... BPR0C261, an analogous of microtubu... Protective effect of CXCR4 antagoni...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目126-150 / 157. (共7页) << < 1 2 3 4 5 6 7 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2008-07-09	Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice	International Journal of Pharmaceutics. 2008 Jul;359(1-2):174-181.
2008-06	Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation	Bioconjugate Chemistry. 2008 Jun;19(6):1248-1255.
2008-03	Decreased expression of UK114 is related to the differentiation status of human hepatocellular carcinoma	Cancer Epidemiology Biomarkers and Prevention. 2008 Mar;17(3):535-542.
2008-02-28	Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet	Journal of Ethnopharmacology. 2008 Feb;116(1):49-57.
2007-08	A randomised placebo-controlled trial of a traditional chinese herbal formula in the treatment of primary dysmenorrhoea	PLoS ONE. 2007 Aug;2(8):Article number e719.
2007-07	Biotransformation of 6-methoxy-3-(3 ',4 ',5 '-trimethoxy-benzoyl)-1-hindole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes	Drug Metabolism and Disposition. 2007 Jul;35(7):1042-1049.
2007-03-14	Novel nanoparticles for oral insulin delivery via the paracellular pathway	Nanotechnology. 2007 Mar;18(10):Article number 105102.
2007-03-01	3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes	Bioorganic and Medicinal Chemistry Letters. 2007 Mar;17(5):1274-1279.
2007-03	Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas	Journal of Biomedical Science. 2007 Mar;14(2):233-244.
2007-02-01	Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: Application to a pharmacokinetic study	Journal of Chromatography B. 2007 Feb;846(1-2):162-168.
2007-01	Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery	Biomacromolecules. 2007 Jan;8(1):146-152.
2006-12	Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats	Journal of Food and Drug Analysis. 2006 Dec;14(4):329-333.
2006-11-25	The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes	Life Sciences. 2006 Nov;79(26):2432-2440.
2006-08	Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control	Journal of Clinical Endocrinology and Metabolism. 2006 Aug;91(8):3084-3087.
2006-07	Non-lethal Candida albicans cph1/cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection	International Journal of Immunopathology and Pharmacology. 2006 Jul-Sep;19(3):561-565.
2006-06-15	Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors	Bioorganic and Medicinal Chemistry Letters. 2006 Jun;16(12):3268-3272.
2006-05-04	Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities	Journal of Medicinal Chemistry. 2006 May;49(9):2703-2712.
2006-03	Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer	Biomaterials. 2006 Mar;27(9):2051-2059.
2006-03	Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells	Bioconjugate Chemistry. 2006 Mar;17(2):291-299.
2006-01-12	2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV	Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380.
2005-12-29	Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities	Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208.
2005-05	Loading of a novel angiogenic agent, ginsenoside Rg(1) in an acellular biological tissue for tissue regeneration	Tissue Engineering. 2005 May;11(5-6):835-846.
2005-04	A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration	Pharmaceutical Research. 2005 Apr;22(4):636-646.
2005-03	Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells	Biomacromolecules. 2005 Mar;6(2):1104-1112.
2004-08-10	Inhibition of human vascular endothelial cells proliferation by terbinafine	International Journal of Cancer. 2004 Aug;111(1):51-59.

显示项目126-150 / 157. (共7页) << < 1 2 3 4 5 6 7 > >> 每页显示[10|25|50]项目